Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chitra Hosing

Showing results (51-60 of 234) with videos related to

Pageof 24
Sort By:
Leukemia & Lymphoma|October 22, 2025
Cladribine and venetoclax combined with alemtuzumab in patients with relapsed/refractory T-cell prolymphocytic leukemiaNaszrin Arani, Caitlin R Rausch, Alexis Geppner, et al.
European Journal of Haematology|September 13, 2017
Inpatient vs outpatient autologous hematopoietic stem cell transplantation for multiple myelomaNina Shah, A Megan Cornelison, Rima Saliba, et al.
American Journal of Hematology|June 11, 2013
Just-in-time rescue plerixafor in combination with chemotherapy and granulocyte-colony stimulating factor for peripheral blood progenitor cell mobilizationVeronica R Smith, Uday Popat, Stefan Ciurea, et al.
The Journal of Infectious Diseases|August 29, 2012
An adaptive randomized trial of an intermittent dosing schedule of aerosolized ribavirin in patients with cancer and respiratory syncytial virus infectionRoy F Chemaly, Harrys A Torres, Mark F Munsell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 12, 2018
Allotransplants for Patients 65 Years or Older with High-Risk Acute Myeloid LeukemiaLauren Veltri, Katayoun Rezvani, Betul Oran, et al.
Transfusion|May 18, 2011
Assessing the charges associated with hematopoietic stem cell mobilization and remobilization in patients with lymphoma and multiple myeloma undergoing autologous hematopoietic peripheral blood stem cell transplantationChitra Hosing, Veronica Smith, Beverly Rhodes, et al.
Cytotherapy|July 12, 2021
Optimal umbilical cord blood collection, processing and cryopreservation methods for sustained public cord blood bankingJoanie Hare, Paulina Garcia DeLeon, Krystle Pool, et al.
Transfusion|February 11, 2017
Patient age and number of apheresis days may predict development of secondary myelodysplastic syndrome and acute myelogenous leukemia after high-dose chemotherapy and autologous stem cell transplantation for lymphomaIsabell Ge, Rima M Saliba, Farzaneh Maadani, et al.
Experimental Hematology|January 17, 2004
Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia: impact of rituximab on immunomodulation and survivalIssa F Khouri, Ming-Sheng Lee, Rima M Saliba, et al.
Blood|July 27, 2007
Long-term follow-up of allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning for patients with chronic myeloid leukemiaPartow Kebriaei, Michelle A Detry, Sergio Giralt, et al.
Pageof 24

Showing results (51-60 of 234) with videos related to

Sort By:
Pageof 24
Leukemia & Lymphoma|October 22, 2025
Cladribine and venetoclax combined with alemtuzumab in patients with relapsed/refractory T-cell prolymphocytic leukemiaNaszrin Arani, Caitlin R Rausch, Alexis Geppner, et al.
European Journal of Haematology|September 13, 2017
Inpatient vs outpatient autologous hematopoietic stem cell transplantation for multiple myelomaNina Shah, A Megan Cornelison, Rima Saliba, et al.
American Journal of Hematology|June 11, 2013
Just-in-time rescue plerixafor in combination with chemotherapy and granulocyte-colony stimulating factor for peripheral blood progenitor cell mobilizationVeronica R Smith, Uday Popat, Stefan Ciurea, et al.
The Journal of Infectious Diseases|August 29, 2012
An adaptive randomized trial of an intermittent dosing schedule of aerosolized ribavirin in patients with cancer and respiratory syncytial virus infectionRoy F Chemaly, Harrys A Torres, Mark F Munsell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 12, 2018
Allotransplants for Patients 65 Years or Older with High-Risk Acute Myeloid LeukemiaLauren Veltri, Katayoun Rezvani, Betul Oran, et al.
Transfusion|May 18, 2011
Assessing the charges associated with hematopoietic stem cell mobilization and remobilization in patients with lymphoma and multiple myeloma undergoing autologous hematopoietic peripheral blood stem cell transplantationChitra Hosing, Veronica Smith, Beverly Rhodes, et al.
Cytotherapy|July 12, 2021
Optimal umbilical cord blood collection, processing and cryopreservation methods for sustained public cord blood bankingJoanie Hare, Paulina Garcia DeLeon, Krystle Pool, et al.
Transfusion|February 11, 2017
Patient age and number of apheresis days may predict development of secondary myelodysplastic syndrome and acute myelogenous leukemia after high-dose chemotherapy and autologous stem cell transplantation for lymphomaIsabell Ge, Rima M Saliba, Farzaneh Maadani, et al.
Experimental Hematology|January 17, 2004
Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia: impact of rituximab on immunomodulation and survivalIssa F Khouri, Ming-Sheng Lee, Rima M Saliba, et al.
Blood|July 27, 2007
Long-term follow-up of allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning for patients with chronic myeloid leukemiaPartow Kebriaei, Michelle A Detry, Sergio Giralt, et al.
Pageof 24